Issue 40 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

21

No.

40

October 20, 1995Oct 20, 1995

Free

DOWNLOAD THE PDF

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

In Brief: Goldman Named Director, Albert Einstein Cancer Center; Wiernik Resumes Post

Fisher Files Motion In Database Flagging Suit; Documents Examine Role Of Former NCI Director Broder

Petition Filed To Revoke NlH License To Use Radioactive Materials

Extramural Advisory Board Members Listed

Komen Foundation Awards New Grants

Recent Issues

Volume 52 | Issue 32 - August 14, 2026

Volume 52 | Issue 31 - August 07, 2026

Volume 52 | Issue 30 - July 31, 2026

Volume 52 | Issue 29 - July 24, 2026

Volume 52 | Issue 28 - July 17, 2026

Volume 52 | Issue 27 - July 10, 2026